<img src="https://secure.intelligence52.com/795232.png" style="display:none;">

Podcast

QCast Episode 73: Respiratory Clinical Trials

By Marketing Quanticate
November 20, 2026
In this episode, Jullia and Tom look at why endpoints such as FEV1, FVC, exacerbation rates and patient-reported outcomes can’t be swapped for one another.
Learn more

QCast Episode 72: Group Sequential Designs in Clinical Trials

By Marketing Quanticate
November 13, 2026
In this episode, Jullia and Tom explain how group sequential designs work in practice, from timing interim looks and setting stopping boundaries.
Learn more

QCast Episode 71: What is a Clinical Development Plan?

By Marketing Quanticate
November 6, 2026
In this episode, Jullia and Tom examine how a CDP turns a development strategy into a connected programme of studies, decisions, and regulatory interactions.
Learn more

QCast Episode 70: Clinical Trial Planning and Design

By Marketing Quanticate
October 30, 2026
In this episode, Jullia and Tom discuss how clinical trial design decisions can have consequences across the protocol, analysis, and delivery of a study.
Learn more

QCast Episode 69: SDTM Mapping Automation Tool

By Marketing Quanticate
October 23, 2026
In this episode, Jullia and Tom examine how SDTM mapping automation tools use approved rules and metadata to generate mapping specifications and SAS code.
Learn more

QCast Episode 68: AI in Clinical Trial Design

By Marketing Quanticate
October 16, 2026
In this episode, Jullia and Tom discuss how predictive modelling, natural language processing, and retrospective analysis can support study planning.
Learn more

QCast Episode 67: The Analysis of Direct and Indirect Pathways in Observational Studies

By Marketing Quanticate
October 9, 2026
In this episode, Jullia and Tom discuss direct and indirect pathways in observational studies, focusing on mediation analysis and what it can and cannot show.
Learn more

QCast Episode 66: What is Clinical Traceability?

By Marketing Quanticate
October 2, 2026
In this episode, Jullia and Tom discuss the challenges of clinical traceability when studies involve multiple systems, CROs, labs, and technology providers.
Learn more

QCast Episode 65: Clinical Trial Trends Shaping Modern Drug Development

By Marketing Quanticate
September 25, 2026
In this episode, Jullia and Tom discuss how recent clinical trial trends are changing practical decisions for sponsors and CROs.
Learn more

QCast Episode 64: Tipping Point Analysis in Clinical Trials

By Marketing Quanticate
September 18, 2026
In this episode, Jullia and Tom discuss how tipping point analysis helps teams understand how strongly a study conclusion depends on missing data assumptions.
Learn more